Index of artpub/2013/302947/

Muñoz, Delicias
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
2013
https://ddd.uab.cat/record/302947